GGrantIndex
Sort

78,016 grants matching breast cancer

A Novel Optical Spectral Imaging System for Rapid Imaging of Breast Tumor Margins

$814,258
Nimmi Ramanujam · Duke University · R01 · FY2015 · EB

FANCONI ANEMIA:GENOTYPE-PHENOTYPE CORRELATIONS

$814,233
Settara Chandrasekharappa · National Human Genome Research Institute · ZIA · FY2014 · HG

Pharmacogenomics of Breast Cancer Adjuvant Chemotherapy

$814,228
Richard M Weinshilboum · Mayo Clinic Rochester · U01 · FY2010 · HG

IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells

$814,121
Albert Sidney Baldwin · Univ Of North Carolina Chapel Hill · R35 · FY2021 · CA

High throughput screening assays to identify chemical probes targeting Hectd3, an E3 ubiquitin ligase implicated in multiple sclerosis

$813,998
Hongmin Li · University Of Arizona · R01 · FY2021 · AI

MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM

$813,998
Rogerio C. Lilenbaum · Mount Sinai Medical Center (Miami Beach) · U10 · FY2007 · CA

Premenopausal Hormone Levels and Risk of Breast Cancer

$813,988
Harvard University (Sch Of Public Hlth) · R01 · FY2005 · CA

Immune reconstitution following autologous and allogeneic stem cell transplant

$813,983
Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA

microRNA expression profiling of benign breast tissue and breast cancer risk

$813,924
Thomas E Rohan · Albert Einstein College Of Medicine · R01 · FY2011 · CA

Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity

$813,838
William Ramses Bishai · Johns Hopkins University · R01 · FY2022 · AI

Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity

$813,838
William Ramses Bishai · Johns Hopkins University · R01 · FY2023 · AI

Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity

$813,838
William Ramses Bishai · Johns Hopkins University · R01 · FY2021 · AI

Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity

$813,838
William Ramses Bishai · Johns Hopkins University · R01 · FY2024 · AI

Cancer Deep Phenotype Extraction from Electronic Medical Records

$813,607
Guergana K. Savova · Boston Children'S Hospital · U24 · FY2024 · CA

Methods for Epidemiology Studies

$813,306
Paul Albert · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA

Novel Targets for Vaccine Therapy

$813,239
Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA

Stroger Hospital of Cook County (SHCC) MU-NCORP Renewal

$813,237
Thomas Lad · Hektoen Institute For Medical Research · UG1 · FY2023 · CA

NCI CFRBCCS INFORMATICS CENTER AT UCI

$813,034
University Of California Irvine · U01 · FY2002 · CA

BREAST CANCER SURVEILLANCE RESEARCH IN NORTH CAROLINA

$812,953
University Of North Carolina Chapel Hill · U01 · FY2004 · CA

CALGB STUDIES OF BREAST CANCER IN THE ELDERLY

$812,872
University Of Chicago · U10 · FY2003 · CA

Longitudinal models of breast cancer for studying mechanisms of therapy response and resistance

$812,870
Bryan E. Welm · University Of Utah · U01 · FY2021 · CA

Vermont Breast Cancer Molecular Characterization Laboratory

$812,868
Janet L Stein · University Of Vermont & St Agric College · U01 · FY2016 · CA

Regulation of Tumor Oxygenation by BACH1 in Breast Cancer

$812,825
Marsha R Rosner · University Of Chicago · R01 · FY2025 · CA

SWOG Biospecimen Bank

$812,707
Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · U24 · FY2020 · CA

Illinois Oncology Research Association Community Clinical Oncology Program

$812,293
Nguyet A. Le-Lindqwister · Oncology-Hematology Assoc-Central Ill · U10 · FY2012 · CA